BillionToOne, Inc. Class A Stock Performance

Open $96.50	Prev. Close $95.48	Circuit Range N/A
Day Range $96.31 - $100.15	Year Range $62.08 - $150.35	Volume 6,330
Average Traded $97.97

BillionToOne, Inc. Class A Share Price Today

As of 10 October 2026, BillionToOne, Inc. Class A's share price is $98.15. The stock opened at $96.50, compared to its previous close of $95.48. During today's trading session, BillionToOne, Inc. Class A's share price traded between $96.31 and $100.15, with an average price of $98.23. Over the past 52 weeks, the stock has recorded a high of $150.35 and a low of $62.08. In terms of performance, BillionToOne, Inc. Class A's share price has risen by 30.84% over the last six months and is down 24.50% on a year-on-year basis.

BillionToOne, Inc. Class A Share Price Chart

$96.31$100.15

BillionToOne, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap $1.56B	PE Ratio (TTM) 149.76	Dividend Yield 0.00%
EPS (TTM) $0.64	Revenue (TTM) $305.11B	Return On Equity (TTM) 5.60%
Profit Margin 0.96%	Debt to Equity 0.17	Quarterly Earnings Growth YoY N/A

BillionToOne, Inc. Class A Quarterly Profit & Loss

All figures in USD

Particulars	Dec 2025	Mar 2026	Jun 2026
Revenue	$96.05	$108.39	$109.45
Net Profit	$2.53	$17.97	$8.05
Net Profit Margin	2.63%	16.58%	7.35%
Income Change	N/A	610.28%	-55.20%

BillionToOne, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars	2025
Revenue	$305.11
Net Profit	$2.92
Net Profit Margin	0.96%
Income Change	N/A

About BillionToOne, Inc. Class A

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

BillionToOne, Inc. Class A Historical Returns

Month	Open	Close	Change %
Oct 2026	$107.47	$98.56	-7.31%
Sep 2026	$92.14	$106.33	+11.84%
Aug 2026	$137.38	$95.08	-31.38%
Jul 2026	$119.91	$138.56	+15.62%
Jun 2026	$95.24	$119.84	+21.25%
May 2026	$73.77	$98.84	+31.76%
Apr 2026	$77.64	$75.02	-4.56%
Mar 2026	$75.50	$78.60	+3.26%
Feb 2026	$85.11	$76.12	-7.85%
Jan 2026	$86.89	$82.60	+0.81%
Dec 2025	$126.25	$81.94	-36.97%
Nov 2025	$104.51	$130.00	N/A

BLLN Share Price FAQs

What is BillionToOne, Inc. Class A share price today?

BillionToOne, Inc. Class A share price today is $98.15 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BillionToOne, Inc. Class A stock?

The 52 week high of BillionToOne, Inc. Class A stock is $150.35, while the 52 week low is $62.08 as of 10 Oct '26.

What is BLLN's market capitalisation today?

BLLN market capitalisation is $1.56B as of October 10, 2026, at 4:41 am IST.

What is BLLN's net income for the last quarter?

BLLN's net income for the last quarter is 8.05B USD.

What is the 5 year returns of BLLN?

The 5 year returns of BLLN is -24.50% as on 10 Oct '26.

What is the high & low stock price of BLLN today?

BLLN stock price hit a high of $100.15 and low of $96.31 as of 10 Oct '26.

Can I buy BLLN shares in India?

Yes. You can buy BLLN in India by opening an international trading account.